At a glance
ClinicalIndex Comparison RecordN/ACompleted· 552 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Diagnostic Accuracy of Procalcitonin as an Early Predictor of Infection After Radical Gastrectomy for Gastric Cancer: a Prospective Bi-center Study
In Brief
An observational study for Gastric Cancer. Completed, enrolled 552 participants across 1 site.
Detailed Summary
To investigate the diagnostic accuracy of procalcitonin as an early predictor of infection after radical gastrectomy for gastric cancer.
Study Details
Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsGastric Cancer
CountriesChina
CollaboratorsHuazhong University of Science and Technology
Timeline
N/ACompletedFinished
20192020202120222023202420252026
Enrollment StartJun 2018
First PostedDec 2018
Primary CompletionJul 2019
TodayJul 2026
First PostedDec 19, 2018
Enrollment StartJun 1, 2018
Primary CompletionJul 28, 2019
TodayJul 2, 2026
Enrollment to primary: 1.2 yearsPosted 7.5 years ago